|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.28 EUR | +0.76% |
|
+10.14% | +20.77% |
| 02-10 | Goldman Turns More Optimistic for Chemicals Sector - Recovery Gains Momentum | DP |
| 02-10 | LANXESS AG : Goldman Sachs drops its Sell rating | ZD |
| Capitalization | 1.84B 2.18B 1.68B 1.6B 2.97B 198B 3.09B 19.49B 7.74B 95.38B 8.18B 8.01B 333B | P/E ratio 2025 * |
-7.55x | P/E ratio 2026 * | -13x |
|---|---|---|---|---|---|
| Enterprise value | 3.87B 4.59B 3.53B 3.37B 6.25B 416B 6.5B 41.05B 16.3B 201B 17.22B 16.87B 702B | EV / Sales 2025 * |
0.67x | EV / Sales 2026 * | 0.67x |
| Free-Float |
94.86% | Yield 2025 * |
0.47% | Yield 2026 * | 0.49% |
Last Transcript: LANXESS AG
| 1 day | +0.76% | ||
| 1 week | +10.14% | ||
| Current month | +21.88% | ||
| 1 month | +23.58% | ||
| 3 months | +18.42% | ||
| 6 months | -12.43% | ||
| Current year | +20.77% |
| 1 week | 19.22 |  | 22.02 |
| 1 month | 16.29 | | 22.02 |
| Current year | 16.29 | | 22.02 |
| 1 year | 15.65 | | 33.93 |
| 3 years | 15.65 | | 45.71 |
| 5 years | 15.65 | | 67.38 |
| 10 years | 15.65 | | 74.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthias Zachert
CEO | Chief Executive Officer | 58 | 31/03/2014 |
Oliver Stratmann
DFI | Director of Finance/CFO | 54 | 31/08/2023 |
Eva Frerker
IRC | Investor Relations Contact | - | 31/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 23/05/2024 | |
Lawrence Rosen
BRD | Director/Board Member | 68 | 12/05/2015 |
Manuela Strauch
BRD | Director/Board Member | 54 | 31/12/2014 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -0.48% | 0.15% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.76% | +10.14% | -28.78% | -52.97% | 2.18B | |
| -4.22% | +7.74% | +14.32% | +42.83% | 67.4B | |
| -0.55% | +6.02% | +0.45% | -1.14% | 53.37B | |
| -1.21% | -0.66% | +4.99% | +28.53% | 16.62B | |
| -1.47% | +2.45% | +69.05% | +84.71% | 15.41B | |
| -1.05% | +4.79% | -10.24% | -16.64% | 9.98B | |
| -1.99% | +4.96% | +41.09% | +47.93% | 9.87B | |
| -1.01% | +4.47% | -4.15% | - | 9.68B | |
| -0.26% | -2.40% | -0.29% | +27.88% | 9.27B | |
| -1.42% | +5.06% | +65.33% | +20.67% | 6.02B | |
| Average | -1.24% | +4.26% | +15.18% | +20.20% | 19.98B | |
| Weighted average by Cap. | -2.03% | +5.21% | +13.65% | +27.24% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.74B 6.81B 5.23B 5B 9.27B 617B 9.64B 60.87B 24.17B 298B 25.54B 25.01B 1,041B | 5.72B 6.79B 5.22B 4.98B 9.24B 615B 9.6B 60.67B 24.09B 297B 25.45B 24.93B 1,038B |
| Net income | -254M -302M -232M -221M -411M -27.34B -427M -2.7B -1.07B -13.2B -1.13B -1.11B -46.14B | -150M -178M -137M -131M -243M -16.15B -252M -1.59B -633M -7.8B -669M -655M -27.26B |
| Net Debt | 2.03B 2.41B 1.85B 1.77B 3.28B 218B 3.41B 21.56B 8.56B 105B 9.04B 8.86B 369B | 1.97B 2.34B 1.79B 1.71B 3.18B 211B 3.3B 20.87B 8.29B 102B 8.76B 8.58B 357B |
Employees
12,338
Sector
Diversified Chemicals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/02/26 | 21.28 € | +0.76% | 478,834 |
| 12/02/26 | 21.12 € | -0.85% | 801,213 |
| 11/02/26 | 21.30 € | -1.30% | 739,244 |
| 10/02/26 | 21.58 € | +11.12% | 1,215,082 |
| 09/02/26 | 19.42 € | +0.52% | 313,318 |
Sell
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
21.28EUR
Average target price
19.41EUR
Spread / Average Target
-8.81%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LXS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition